In The Sea Of Biotechs, Anthera's Multi-Drug Pipeline Makes It Attractive
September 17, 2015 at 11:43 AM EDT
Anthera Pharmaceuticals Inc (NASDAQ: ANTH) shares are down 5 percent since August 18, remaining below the $10 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.